ABSTRACT
OBJECTIVES: A simple, robust method, for optimising cone-beam CT (CBCT) dose and image quality for pelvis treatment, based on patient-specific attenuation. METHODS: Methods were investigated for grouping patients into four imaging categories (small [S], medium [M], large [L], extra large [XL]), based on planning-CT CTDIvol, and phantoms constructed to represent each group. CBCTs with varying kV, mA and ms honed in on the best settings, with a bladder noise of 25 HU. A patient pilot study clinically verified the new imaging settings. RESULTS: The planning CTDIvol is a reliable method for grouping patients. Phantom measurements from the S, M and L groups show doses significantly reduced (19-83% reduction), whilst the XL group required an increase of 39%. Phantom TLD measurements showed the number of scans needed to increase rectal organ at risk (OAR) dose by 1 Gy was 143 (S group) and 50 (M group). Images were qualitatively assessed as sufficient by clinicians. CONCLUSION: Patient-specific CBCT modes are in use clinically with dose reductions across all modes except Pelvis XL, keeping doses ALARP and images optimal. Consideration of OAR doses controls the number of CBCTs allowed to ensure adherence to OAR tolerance. Reporting CBCT doses in "scans per Gray" allows clinicians to make informed decisions regarding the imaging schedule and concomitant doses. ADVANCES IN KNOWLEDGE: Patient grouping at planning CT, using CTDIvol, allows for CBCT imaging protocols to be selected based on patient specific attenuation. Reporting OAR doses in terms of "scans per Gray" allows translation of imaging dose risk to the Oncologist.
Subject(s)
Cone-Beam Computed Tomography , Pelvic Neoplasms/radiotherapy , Radiotherapy Dosage , Radiotherapy, Image-Guided , Female , Humans , Male , Phantoms, Imaging , Pilot Projects , Radiation Dosage , Retrospective StudiesABSTRACT
OBJECTIVE: Towards Safer Radiotherapy recommended that radiotherapy (RT) centres should have protocols in place for in vivo dosimetry (IVD) monitoring at the beginning of patient treatment courses (Donaldson S. Towards safer radiotherapy. R Coll Radiol 2008). This report determines IVD implementation in the UK in 2014, the methods used and makes recommendations on future use. METHODS: Evidence from peer-reviewed journals was used in conjunction with the first survey of UK RT centre IVD practice since the publication of Towards Safer Radiotherapy. In March 2014, profession-specific questionnaires were sent to radiographer, clinical oncologist and physics staff groups in each of the 66 UK RT centres. RESULTS: Response rates from each group were 74%, 45% and 74%, respectively. 73% of RT centres indicated that they performed IVD. Diodes are the most popular IVD device. Thermoluminescent dosimeter (TLD) is still in use in a number of centres but not as a sole modality, being used in conjunction with diodes and/or electronic portal imaging device (EPID). The use of EPID dosimetry is increasing and is considered of most potential value for both geometric and dosimetric verification. CONCLUSION: Owing to technological advances, such as electronic data transfer, independent monitor unit checking and daily image-guided radiotherapy, the overall risk of adverse treatment events in RT has been substantially reduced. However, the use of IVD may prevent a serious radiation incident. Point dose IVD is not considered suited to the requirements of verifying advanced RT techniques, leaving EPID dosimetry as the current modality likely to be developed as a future standard. Advances in knowledge: An updated perspective on UK IVD use and provision of professional guidelines for future implementation.
Subject(s)
In Vivo Dosimetry/methods , Radiation Dosimeters , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Intensity-Modulated/instrumentation , Radiotherapy, Intensity-Modulated/methods , Humans , Radiotherapy Dosage , Surveys and Questionnaires , Thermoluminescent Dosimetry , United KingdomABSTRACT
OBJECTIVE: The purpose of this work was to assess heating and radiofrequency (RF) deposition and image quality effects of a prototype three-section carbon fibre flatbed insert for use in MRI. METHODS: RF deposition was assessed using two different thermometry techniques, infrared thermometry and Bragg-grating thermometry. Image quality effects were assessed with and without the flatbed insert in place by using mineral oil phantoms and a human subject. RESULTS: Neither technique detected heating of the insert in typical MRI examinations. We found that the insert was less suitable for MRI applications owing to severe RF shielding artefact. For spin-echo (SE), turbo spin-echo (TSE) and gradient-echo sequences, the reduction in signal-to-noise ratio (SNR) was as much as 89% when the insert was in place compared with the standard couch, making it less suitable as a patient-support material. Turning on the MultiTransmit switch together with using the scanner's quadrature body coil improved the reduction in SNR from 89% to 39% for the SE sequence and from 82% to 12% for the TSE sequence. CONCLUSION: No evidence was found to support reports in the literature that carbon fibre is an unsuitable material for use in MRI because of heating. ADVANCES IN KNOWLEDGE: This study suggests that carbon fibre is less suitable for large-scale MRI applications owing to it causing severe RF shading. Further research is needed to establish the suitability of the flatbed for treatment planning using alternative sequences or whether an alternative carbon fibre composite for large-scale MRI applications or a design that can minimize shielding can be found.